Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Placebo for Postoperative Inflammation After ACL Reconstruction
NCT07332910Phase 4Not yet recruiting
- Sponsor
- CHIREC
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in hemarthrosis, sponsored by CHIREC. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
hemarthrosis
Beyond the preview
Go deeper on NCT07332910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07332910.